Lilly's Alimta gets CHMP rec for new uses; Teva breaks ground on $300M Philadelphia facility;

@FiercePharma: Turns out that fixing Genzyme's manufacturing woes is proving tougher than Sanofi thought. Item | Follow @FiercePharma

> Eli Lilly's cancer drug Alimta won a recommendation from a European regulatory committee for two new indications in lung cancer. Report

> Teva Pharmaceutical Industries broke ground on a new $300 million, three-building distribution center in Philadelphia. More

> Authors of a new study recommend stronger asthma warnings on hormone replacement therapies. Report

> Ipsen has in-licensed Hexvix, a fluorescence agent designed to improve detection and surgery in bladder cancer, from Photocure and GE Healthcare for €19 million up front, plus at least €5 million in milestone payments. Release

> Aiming to expand its consulting services, drug distributor AmerisourceBergen agreed to buy TheraCom from CVS Caremark for $250 million. Article

> European drug distributor Celesio is bowing out of its drug-compliance services joint venture with Medco Health Solutions. Piece

Biotech News

 @FierceBiotech: Novartis seeking approval for NVA237 for smoker's cough after trials showed it helped patients breathe more easily. News | Follow @FierceBiotech

 @RyanMFierce: @FierceMedDev and @arsalanfierce will be tweeting from #AdvaMed2011 this week. Have fun in DC this week! | Follow @RyanMFierce

 @MaureenFierce: Reading: Predicting tox on a chip? DARPA soliciting proposal, could award 5 years of funding. Story | Follow @MaureenFierce

 @FierceMedDev: Mazzo: adding more funding won't address problems at FDA. Fundamental issues won't be addressed by throwing money at problem. #AdvaMed2011 | Follow @FierceMedDev

> Cancer drug shortages threaten to derail hundreds of clinical trials. News

> Biotech accused deposed CEO of doctoring resume, stock scheme. Story

Pharma Manufacturing News

> Bayer, union at odds over outsourcing promised jobs. Report

> Barcode is India's choice of track/trace weapon. Story

> Taiwan take-down nets fakes-makers, retailers. Report

> Drug in regulatory limbo a headache for Shire, FDA. Piece

> Merck, MedImmune deal space. More

Biotech Research News

> Fred Hutch sequencing project unveils key triggers for prostate cancer. Item

> NIH buddies with Afraxis to escort Fragile X program through "valley of death". Article

> Johns Hopkins researcher designs self-destruct switch for cancer cells. Report

> Sequencing leaders want industry standards to govern decoded DNA. More

And Finally... Women who regularly drink caffeinated coffee have a 20% lower risk of depression. Report

Suggested Articles

Six pharmaceutical execs are set to head to Washington next week for pricing hearings at the House Committee on Oversight and Reform. 

After sifting through the data, one analyst figures the latest Opdivo-Keytruda showdown in kidney cancer might come down to commercial execution.

Biogen is giving former chief finance officer Jeff Capello a multimillion-dollar cash payment plus other severance benefits.